prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: Invasive ductal carcinóma in the left breast at 10 o'clock. Calcifications. and atypia at 12 o'clock. LMP DATE: Not listed. PROCEDURE: Left segmental mastectomy, sentinel lymph node biopsy, excisional biopsy. SPECIFIC CLINICAL QUESTION: Not listed. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: LEFT BREAST, 40 O'CLOCK, SEGMENTAL MASTECTOMY -. A. TWO FOCI OF INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: TOTAL SCORE: 7/9). 2;. C. THE DOMINANT MASS OF INVASIVE CARCINOMA MEASURES 1.9 CM IN LARGEST DIMENSION. D. THE SATELLITE FOCUS MEASURES 0.6 CM AND IS PRESENT 0.5 CM AWAY FROM THE MAIN MASS. E. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE. F. THE DCIS CONSTITUTES 10% OF THE TOTAL TUMOR VOLUME AND IS ADMIXED WITH INVASIVE. COMPONENT. G. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. H. THE INVASIVE CARCINOMA (DOMINANT MASS) FOCALLY EXTENDS TO THE SUPERIOR MARGIN AND IS. <0.1 CM TO THE POSTERO-INFERIOR MARGIN. I. THE SATELLITE FOCUS OF INVASIVE CARCINOMA IS 0.15 CM FROM THE POSTERIOR MARGIN. J. FLAT EPITHELIAL ATYPIA. K. CALCIFICATIONS ARE ASSOCIATED WITH INVASIVE CARCINOMA AND BENIGN BREAST PARENCHYMA. L. THE NON-NEOPLASTIC BREAST SHOWS FLORID DUCTAL HYPERPLASIA, COLUMNAR CELL CHANGE AND. FIBROCYSTIC CHANGES. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H- score 240) AND POSITIVE. FOR PROGESTERONE RECEPTOR (H-score 240) AND NEGATIVE FOR HER-2, AS PER PREVIOUS. PART 2: LEFT BREAST, 12 O'CLOCK, BIOPSY -. A. FLORID DUCTAL HYPERPLASIA. B. COLUMNAR CELL CHANGES AND HYPERPLASIA. C. RADIAL SCAR. D. FIBROADENOMATOID AND FIBROCYSTIC CHANGES. E. NO RESIDUAL ATYPIA SEEN. F. PREVIOUS BIOPSY SITE. PART 3: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. A. ONE LYMPH NODE, POSITIVE FOR METASTATIC TUMOR (1/1). B. THE METASTATIC FOCUS MEASURES 0.6 CM IN LARGEST DIMENSION. C. FOCAL EXTRACAPSULAR EXTENSION (<0.1 CM) IS IDENTIFIED. PART 4: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/2). COMMENT: The invasive tumor nuclear grade is variable and ranges-from nuclear grade 2 to nuclear grade 3. The highest grade is. taken into account for Nottingham scoring and grading. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Antibody/Antigen. E-cadherin. Membranous reactivity in invasive tumor cells. P120. Membranous reactivity in invasive tumor cells. Utilizing formalin-fixed (8-96 hour range), paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone (s) directed. against the following antigenic target (s) with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. E-cadherin. 36. Ductal Carcinoma. P120. 98. Lobular carcinoma. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position: 10.00. SIZE OF TUMOR: Maximum dimension invasive component: 19 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.5 mm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Yes, focal. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 6 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Yes, Maximum size is:0.75mm. NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNX. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 240. PROGESTERONE RECEPTORS: positive, H-score: 240. HER2/NEU: 1+. Comment: The tumor pN stage is at least pN1. Since the sentinel node is positive, a final N. stage will be assigned after complete lymph node dissection.

expanded version (tokens=1940) : 
 Histological classification: Invasive ductal carcinoma, no special type with nuclear grade 2 (Tubule formation: 2, Nuclear pleomorphism: 3, Mitotic activity: Total score: 7/9), Ductal carcinoma in-situ (DCIS), nuclear grade 2, cribriform type, Radial scar, Florid ductal hyperplasia, Columnar cell changes and hyperplasia.

Subtype: LumA.

Necrosis: Not mentioned.

Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes.

Histological grade: The Nottingham grade is 2.

Nuclear grade: The nuclear grade ranges from 2 to 3. The highest grade is taken into account for Nottingham scoring and grading.

Lymphovascular invasion: No lymphovascular space invasion is noted.

Calcification: Calcifications are associated with invasive carcinoma and benign breast parenchyma.

Receptor status: The invasive tumor cells are positive for estrogen receptor (H-score 240) and positive for progesterone receptor (H-score 240) and negative for HER-2.

Ancillary testing results: One lymph node was positive for metastatic tumor (1/1). Focal extracapsular extension (<0.1 cm) is identified. E-cadherin membrane reactivity seen in invasive tumor cells. P120 membranous reactivity seen in invasive tumor cells. The tumor pN stage is at least p

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2108) : 
 LumA subtype with invasive ductal carcinoma, no special type, and DCIS cribriform type. Nuclear grade is 2 and Nottingham grade score is 7/9. Positive estrogen and progesterone receptors and negative for HER-2 receptors. Calcifications are associated with both invasive carcinoma and benign parenchyma. One of three examined lymph nodes has a metastatic tumor with the maximum diameter of 6mm and focal extracapsular extension (<0.1 cm). A final N stage will be assigned after complete lymph node dissection due to positive sentinel node biopsy result.

